CRL · Company research
Charles River Laboratories International, Inc. (CRL): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Here’s How Much You Would Have Made Owning Charles River Stock In The Last 20 Years - Benzinga | Here’s How Much You Would Have Made Owning Charles River Stock In The Last 20 Years Benzinga | View source ↗ | Benzinga | Oct 14, 2026 | neutral | 0 | 0.6 |
| A stem cell treatment for osteoarthritis completed initial trials. Its next study is being prepared. - Stock Titan | A stem cell treatment for osteoarthritis completed initial trials. Its next study is being prepared. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera | The global synthetic antibody library market is projected to grow from $1.63 billion in 2025 to $2.86 billion by 2030, representing a 12% CAGR. Growth is driven by AI-integrated antibody design, increased demand for therapeutic antibodies, high-throughput screening technologies, and expansion of contract research organizations. North America leads the market while Asia-Pacific shows fastest growth potential. | View source ↗ | GlobeNewswire Inc. | Oct 12, 2026 | bullish | 1 | 1 |
| Charles River Laboratories International, Inc. (CRL) stock price, news, quote and history - Yahoo Finance UK | Charles River Laboratories International, Inc. (CRL) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 10, 2026 | neutral | 0 | 0.6 |
| Charles River Laboratories International, Inc. (CRL) stock price, news, quote and history - Yahoo Finance Singapore | Charles River Laboratories International, Inc. (CRL) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 9, 2026 | neutral | 0 | 0.6 |
| Charles River Laboratories International, Inc. (CRL) Stock Price, News, Quote & History - Yahoo! Finance Canada | Charles River Laboratories International, Inc. (CRL) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| PGNY or CRL: Which Is the Better Value Stock Right Now? | A comparison of two Medical Services stocks reveals that Progyny (PGNY) presents a more attractive value investment opportunity than Charles River Laboratories (CRL). PGNY has a Zacks Rank of #2 (Buy) versus CRL's #3 (Hold), along with superior valuation metrics including a lower forward P/E ratio (12.40 vs 26.89) and a better Value grade (B vs D). | View source ↗ | Zacks Investment Research | Oct 7, 2026 | neutral | 0 | 1 |
| PGNY or CRL: Which Is the Better Value Stock Right Now? - Yahoo! Finance Canada | PGNY or CRL: Which Is the Better Value Stock Right Now? Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 7, 2026 | neutral | 0 | 0.6 |
| Charles River Gains 75.8% in a Year: What's Driving the Rally? | Charles River Laboratories (CRL) has outperformed the market with a 75.8% share price increase over the past year, driven by strong Research Models and Services (RMS) prospects and adoption of new approach methodologies. However, the company faces headwinds from uneven demand recovery across client segments, with small and midsized biotech revenues flat and currency fluctuations impacting reported growth. The company maintains a Zacks Rank #3 (Hold) rating. | View source ↗ | Zacks Investment Research | Oct 7, 2026 | bullish | 0.75 | 1 |
| Charles River Gains 75.8% in a Year: What's Driving the Rally? - TradingView | Charles River Gains 75.8% in a Year: What's Driving the Rally? TradingView | View source ↗ | TradingView | Oct 7, 2026 | neutral | 0 | 0.6 |
| Lab samples, testing and review now connect in one digital workflow - Stock Titan | Lab samples, testing and review now connect in one digital workflow Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| An officer proposes selling 981 option-acquired shares of Charles River (CRL). - Stock Titan | An officer proposes selling 981 option-acquired shares of Charles River (CRL). Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Charles River Laboratories (CRL) Stock Fair Value Rises After Analyst Day Target Increases - Yahoo Finance | Charles River Laboratories (CRL) Stock Fair Value Rises After Analyst Day Target Increases Yahoo Finance | View source ↗ | Yahoo Finance | Oct 2, 2026 | neutral | 0 | 0.6 |
| Charles River Laboratories (CRL) Stock Still Seems Reasonable Despite Rapid Cell Banking Launch - Yahoo Finance | Charles River Laboratories (CRL) Stock Still Seems Reasonable Despite Rapid Cell Banking Launch Yahoo Finance | View source ↗ | Yahoo Finance | Sep 25, 2026 | neutral | 0 | 0.6 |
| Why Charles River Laboratories (CRL) Stock Is Up Today - Yahoo Finance | Why Charles River Laboratories (CRL) Stock Is Up Today Yahoo Finance | View source ↗ | Yahoo Finance | Sep 24, 2026 | neutral | 0 | 0.6 |
| Over $300 million in savings is expected as Charles River automates and simplifies work, 2027–30. - Stock Titan | Over $300 million in savings is expected as Charles River automates and simplifies work, 2027–30. Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| Why Charles River Laboratories (CRL) Stock Is Trading Up Today - Yahoo Finance | Why Charles River Laboratories (CRL) Stock Is Trading Up Today Yahoo Finance | View source ↗ | Yahoo Finance | Sep 17, 2026 | neutral | 0 | 0.6 |
| Charles River Laboratories International (CRL) Stock Fair Value Rises After Analysts Lift Targets - Yahoo Finance | Charles River Laboratories International (CRL) Stock Fair Value Rises After Analysts Lift Targets Yahoo Finance | View source ↗ | Yahoo Finance | Sep 17, 2026 | neutral | 0 | 0.6 |
| Charles River (NYSE: CRL) director exercises options, sells stock at $300 - Stock Titan | Charles River (NYSE: CRL) director exercises options, sells stock at $300 Stock Titan | View source ↗ | Stock Titan | Aug 27, 2026 | neutral | 0 | 0.6 |
| Charles River (NYSE: CRL) director plans new sale after $24.8M stock sales - Stock Titan | Charles River (NYSE: CRL) director plans new sale after $24.8M stock sales Stock Titan | View source ↗ | Stock Titan | Aug 25, 2026 | neutral | 0 | 0.6 |
| Why Charles River Laboratories (CRL) Stock Is Up Today - Quiver Quantitative | Why Charles River Laboratories (CRL) Stock Is Up Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 5, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.